Plasminogen activator inhibitor type-1 (PAI-1) expression relates to the presence of myocardial inflammation in patients with nonischemic cardiomyopathy

dc.contributor.authorEscher, F. Felicitas
dc.contributor.authorAgirbasli, M. E.
dc.contributor.authorLassner, D. L.
dc.contributor.authorAleshcheva, G. A.
dc.contributor.authorSchultheiss, H. P. S.
dc.date.accessioned2025-05-10T19:28:07Z
dc.date.issued2019
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.endpage129
dc.identifier.issn1388-9842
dc.identifier.issn1879-0844
dc.identifier.scopusqualityQ1
dc.identifier.startpage128
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7209
dc.identifier.volume21
dc.identifier.wosWOS:000468990702012
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofEuropean Journal of Heart Failure
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titlePlasminogen activator inhibitor type-1 (PAI-1) expression relates to the presence of myocardial inflammation in patients with nonischemic cardiomyopathy
dc.typeConference Object

Dosyalar